Self-injections Market Intelligence Report - Global Forecast to 2027

Self-injections Market Intelligence Report - Global Forecast to 2027

The Global Self-injections Market is projected to reach USD 86,009.00 million by 2027 from USD 41,757.64 million in 2021, at a CAGR 12.79% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

• The Americas Self-injections Market size was estimated at USD 14,480.50 million in 2021 and expected to reach USD 15,973.70 million in 2022, at a CAGR 12.26% to reach USD 28,987.16 million by 2027.
• The Asia-Pacific Self-injections Market size was estimated at USD 11,116.51 million in 2021 and expected to reach USD 12,557.66 million in 2022, at a CAGR 13.14% to reach USD 23,321.48 million by 2027.
• The Europe, Middle East & Africa Self-injections Market size was estimated at USD 16,160.62 million in 2021 and expected to reach USD 18,199.61 million in 2022, at a CAGR 13.03% to reach USD 33,700.35 million by 2027.

Market Segmentation & Coverage:

The report on self-injections identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the self-injections to forecast the revenues and analyze the trends in each of the following sub-markets:

Type:

• Auto-Injectors
• Needle-free Injectors
• Pen Injectors
• Wearable Injectors

Usage:

• Disposable
• Reusable

Distribution Channel:

• Hospital Pharmacies
• Online Pharmacies
• Private Clinics

Therapeutic Areas Application:

• Autoimmune Diseases
  • AIDS
  • Allergies
  • Cancer
  • Irritable Bowel Disorders
  • Multiple Sclerosis
  • Psoriasis
• Emergency Drugs
  • Anaphylactic Socks
  • Migraine
• Hormone Replacement Therapies
  • Beta-Interferon
  • Erythropoietin
  • Follicle Stimulating Hormone
  • Heparin
  • Insulin
  • Parathyroid Hormone
  • Parkinson’s

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • California
    • Florida
    • Illinois
    • New York
    • Ohio
    • Pennsylvania
    • Texas
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

Company Usability Profiles:

• AbbVie Inc.
• Antares Pharma, Inc.
• Baxter International, Inc.
• Becton, Dickinson and Company
• Credence MedSystems, Inc.
• DALI Medical Devices
• Eli Lilly and Company
• Enable Injections, Inc.
• Gerresheimer AG
• Insulet Corporation
• Owen Mumford Limited
• PenJet Corporation
• Pfizer Inc.
• PharmaJet, Inc.
• Recipharm AB
• SCHOTT AG
• SHL Group
• Terumo Corporation
• West Pharmaceutical Services, Inc.
• Wilhelm Haselmeier GmbH & Co. KG
• Ypsomed Group